SCHEMBL20143350

SCHEMBL20143350

Cc1ccc(C(=O)Nc2ccc(CN3CCN(CN4CCN(Cc5ccc(NC(=O)c6ccc(C)c(C#Cc7cnc8cccnn78)c6)cc5C(F)(F)F)CC4)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 20/20 0.91
CYP3A4 P08684 3/20 0.91
KCNH2 Q12809 3/20 0.91
ABL2 P42684 2/20 0.91
GAK O14976 1/20 0.91
MLNR O43193 1/20 0.91
RIPK2 O43353 1/20 0.91
JAK2 O60674 1/20 0.91
NR1I2 O75469 1/20 0.91
ABCB11 O95342 1/20 0.91
MAP4K4 O95819 1/20 0.91
EGFR P00533 1/20 0.91
NR3C1 P04150 1/20 0.91
ERBB2 P04626 1/20 0.91
NTRK1 P04629 1/20 0.91
LCK P06239 1/20 0.91
FYN P06241 1/20 0.91
PGR P06401 1/20 0.91
CSF1R P07333 1/20 0.91
YES1 P07947 1/20 0.91

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15294699 0.95 ABL1 (1.00) ABL1CYP3A4KCNH2ABL2GAK
Ponatinib SCHEMBL589260 0.95 ABL1 (1.00) ABL1CYP3A4KCNH2ABL2GAK
Ponatinib SCHEMBL29353054 0.95 ABL1 (1.00) ABL1CYP3A4KCNH2ABL2GAK
Ponatinib SCHEMBL29373892 0.95 ABL1 (1.00) ABL1CYP3A4KCNH2ABL2GAK
Ponatinib SCHEMBL29889039 0.95 ABL1 (1.00) ABL1CYP3A4KCNH2ABL2GAK
SCHEMBL24685833 0.95 ABL1 (0.90) ABL1CYP3A4KCNH2ABL2GAK
SCHEMBL15144985 0.95 ABL1 (0.89) ABL1CYP3A4KCNH2ABL2GAK
Ponatinib SCHEMBL16797824 0.94 ABL1 (0.99) ABL1CYP3A4KCNH2ABL2GAK
SCHEMBL17235949 0.94 ABL1 (0.88) ABL1CYP3A4KCNH2ABL2GAK
SCHEMBL16250601 0.94 ABL1 (0.88) ABL1CYP3A4KCNH2ABL2GAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969753-B2 BCR-ABL diploid inhibitor, synthesizing method therefor, and uses thereof SHENZHEN YONGZE PHARMACEUTICAL CO., LTD. (CN) 2018-05-15 US disclosed